Evidence map›Paper›PMID 28550307›Full record

ArticleScientific reports2017

Therapeutic effects of matrine derivate MASM in mice with collagen-induced arthritis and on fibroblast-like synoviocytes.

Yuming Zou, Quan Li, Denghui Liu, Jia Li, Qing Cai, Chao Li, Qingjie Zhao, Weidong Xu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yuming ZouDepartment of Orthopedics, Changhai hospital, the first affiliated hospital of the Second Military Medical University, Shanghai, 200433, P.R. China.
Quan LiDepartment of Orthopedics, Changhai hospital, the first affiliated hospital of the Second Military Medical University, Shanghai, 200433, P.R. China.
Denghui LiuDepartment of Orthopedics, Changhai hospital, the first affiliated hospital of the Second Military Medical University, Shanghai, 200433, P.R. China.
Jia LiDepartment of Orthopedics, Changhai hospital, the first affiliated hospital of the Second Military Medical University, Shanghai, 200433, P.R. China.
Qing CaiDepartment of Rheumatology, Changhai hospital, Second Military Medical University, Shanghai, 200433, P.R. China.
Chao LiDepartment of Organic Chemistry, School of Pharmacy, the first affiliated hospital of the Second Military Medical University, Shanghai, 200433, P.R. China.
Qingjie ZhaoDepartment of Organic Chemistry, School of Pharmacy, the first affiliated hospital of the Second Military Medical University, Shanghai, 200433, P.R. China. qjzhao@smmu.edu.cn.
Weidong XuDepartment of Orthopedics, Changhai hospital, the first affiliated hospital of the Second Military Medical University, Shanghai, 200433, P.R. China. xwdsmmu@163.com.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MASM is a matrine derivate that exhibits a number of pharmacological effects, including immunosuppressive activity and anti-inflammatory properties. In this study, the mechanisms underlying the therapeutic efficacy of MASM in the treatment of rheumatoid arthritis were investigated using DBA/1 mice with collagen-induced arthritis (CIA) and fibroblast-like synoviocytes derived from rheumatoid arthritis patients (RA-FLS). We demonstrated that MASM markedly attenuated the severity of arthritis in CIA mice. The therapeutic effects were associated with ameliorated joint swelling and reduced bone erosion and destruction. Furthermore, the administration of MASM suppressed the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). In vitro, MASM inhibited the expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-8) and matrix metalloproteinases (MMP-1, MMP-3 and MMP-13) by inhibiting both the phosphorylation of MAPKs and the activation of NF-κB in IL-1β-stimulated RA-FLS. Additionally, MASM could induce apoptosis of RA-FLS via mitochondrial and Akt signaling pathways in human RA-FLS. These findings suggest that MASM could attenuate arthritis severity in CIA mice at least partially by blocking the phosphorylation of MAPKs and the activation of NF-κB and by inducing apoptosis in RA-FLS. MASM could be a potent therapeutic agent for the treatment of RA.

Indexed as

AlkaloidsAnimalsApoptosisApoptosis Regulatory ProteinsArthritis, ExperimentalArthritis, RheumatoidCytokinesFibroblastsHumansInflammation MediatorsMaleMatrinesMice, Inbred DBAQuinolizinesSignal TransductionSynovial MembraneAlkaloidsApoptosis Regulatory ProteinsCytokinesInflammation MediatorsMatrinesQuinolizines

Identifiers

PMID28550307
PMCPMC5446426
OpenAlexW2620474481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.